Page 25 - รายงานประจำปี ๒๕๕๙ ศูนย์องค์รวมเพื่อการศึกษาและบำบัดโรคมะเร็ง คณะแพทยศาสตร์

Clinical Studies

1. Lung Cancer
1.1 First line, stage II-IIIA NSCLC : ADAURA
1.2 First line, stage IIIB-IV NSCLC : FLAURA 1
1.3 First line, EGFR vaccine, stage IV NSCLC: BV-NSCLC-002

2. First line, HER2 +ve Metastatic Gastric Cancer: IMU-131

3. Advanced Solid Tumors : SBG

4. Second line, Metastatic colorectal : AB12006

5. First line, Recurrent/Metastatic head and neck squamous cell carcinoma: KESTREL

6. Second line, Locally Advanced recurrent/metastatic nasopharyngeal carcinoma : CPDR001X2201

7. Second line, Recurrent/Metastatic head and neck squamous cell carcinoma : BI1200.161

8. Stage IV, Recurrent/Metastatic renal cell carcinoma: RCC

9. Locally Advanced or Metastatic Breast Cancer
9.1 ER+ve, HER2 -ve: SANDPIPER (GO29058)
9.2 ER-ve, PR-ve, HER2-ve: IMPASSION (WO29522)

10. Stage IIIC-IV, Acral Lentiginous or cutaneous melanoma

25